| Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial A Engert, H Haverkamp, C Kobe, J Markova, C Renner, A Ho, J Zijlstra, ... The Lancet 379 (9828), 1791-1799, 2012 | 743 | 2012 |
| Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer RD Hofheinz, SE Al-Batran, F Hartmann, G Hartung, D Jäger, C Renner, ... Oncology Research and Treatment 26 (1), 44-48, 2003 | 370 | 2003 |
| Expression of RHAMM/CD168 and other tumor-associated antigens in patients with B-cell chronic lymphocytic leukemia K Giannopoulos, L Li, A Bojarska-Junak, J Rolinski, A Dmoszynska, I Hus, ... International journal of oncology 29 (1), 95-103, 2006 | 309 | 2006 |
| Structural and kinetic basis for heightened immunogenicity of T cell vaccines JL Chen, G Stewart-Jones, G Bossi, NM Lissin, L Wooldridge, EML Choi, ... The Journal of experimental medicine 201 (8), 1243-1255, 2005 | 308 | 2005 |
| Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes S Bauer, MC Jendro, A Wadle, S Kleber, F Stenner, R Dinser, A Reich, ... Arthritis research & therapy 8, 1-11, 2006 | 234 | 2006 |
| Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells PC Schuberth, C Hagedorn, SM Jensen, P Gulati, M van den Broek, ... Journal of translational medicine 11, 1-11, 2013 | 200 | 2013 |
| Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 VJ Craig, SB Cogliatti, J Imig, C Renner, S Neuenschwander, H Rehrauer, ... Blood, The Journal of the American Society of Hematology 117 (23), 6227-6236, 2011 | 200 | 2011 |
| Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells C Renner, W Jung, U Sahin, R Denfeld, C Pohl, L Trumper, F Hartmann, ... Science 264 (5160), 833-835, 1994 | 195 | 1994 |
| Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody F Hartmann, C Renner, W Jung, C Deisting, M Juwana, B Eichentopf, ... Blood, The Journal of the American Society of Hematology 89 (6), 2042-2047, 1997 | 187 | 1997 |
| Final results of a prospective evaluation of the predictive value of interim positron emission tomography in patients with diffuse large B-cell lymphoma treated with R-CHOP-14 … C Mamot, D Klingbiel, F Hitz, C Renner, T Pabst, C Driessen, U Mey, ... Journal of clinical oncology: official journal of the American Society of …, 2015 | 184 | 2015 |
| microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma J Imig, N Motsch, JY Zhu, S Barth, M Okoniewski, T Reineke, M Tinguely, ... Nucleic acids research 39 (5), 1880-1893, 2011 | 179 | 2011 |
| Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata CE Brokopp, R Schoenauer, P Richards, S Bauer, C Lohmann, ... European heart journal 32 (21), 2713-2722, 2011 | 147 | 2011 |
| Rational development of high-affinity T-cell receptor-like antibodies G Stewart-Jones, A Wadle, A Hombach, E Shenderov, G Held, E Fischer, ... Proceedings of the National Academy of Sciences 106 (14), 5784-5788, 2009 | 144 | 2009 |
| Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins VJ Craig, I Arnold, C Gerke, MQ Huynh, T Wündisch, A Neubauer, ... Blood, The Journal of the American Society of Hematology 115 (3), 581-591, 2010 | 138 | 2010 |
| Anti-CD16/CD30 bispecific antibody treatment for Hodgkin’s disease: role of infusion schedule and costimulation with cytokines F Hartmann, C Renner, W Jung, L da Costa, S Tembrink, G Held, A Sek, ... Clinical cancer research 7 (7), 1873-1881, 2001 | 131 | 2001 |
| EB/RP gene family encodes tubulin binding proteins JP Juwana, P Henderikx, A Mischo, A Wadle, N Fadle, K Gerlach, ... International journal of cancer 81 (2), 275-284, 1999 | 111 | 1999 |
| A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma C Renner, PL Zinzani, R Gressin, D Klingbiel, PY Dietrich, F Hitz, ... Haematologica 97 (7), 1085, 2012 | 107 | 2012 |
| T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28 C Renner, S Ohnesorge, G Held, S Bauer, W Jung, JP Pfitzenmeier, ... | 107 | 1996 |
| Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer A Mischo, B Kubuschok, K Ertan, KD Preuss, B Romeike, E Regitz, ... International Journal of Cancer 118 (3), 696-703, 2006 | 106 | 2006 |
| Radioimmunotherapy of fibroblast activation protein positive tumors by rapidly internalizing antibodies E Fischer, K Chaitanya, T Wüest, A Wadle, AM Scott, M van den Broek, ... Clinical cancer research 18 (22), 6208-6218, 2012 | 103 | 2012 |
